Insider Trading - Versant Vantage I GP-GP LLC

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Versant Vantage I GP-GP LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-10-18
Sale
2021-10-20
4:38 pm
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
550,000 $14.84 $8,160,736 3,245,533
(Indirect
Direct)
View
2021-06-28
Purchase
2021-06-30
5:00 pm
Monte Rosa Therapeutics Inc. GLUE Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
157,895 $19 $3,000,005 8,897,053
(Indirect
Direct)
View
2020-06-23
Purchase
2020-06-25
7:40 pm
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
250,000 $20 $5,000,000 3,419,451
(Indirect)
View
2020-03-03
Purchase
2020-03-03
7:03 pm
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
225,000 $18 $4,050,000 4,959,769
(Indirect
Direct)
View
2019-11-04
Purchase
2019-11-04
5:58 pm
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
590,000 $16 $9,440,000 3,565,546
(Indirect
Direct)
View
2019-10-07
Purchase
2019-10-07
7:40 pm
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
333,333 $15 $4,999,995 2,852,656
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-05
Other
2022-01-07
4:20 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
253,030 $0 3,547,597
(Indirect)
View
2021-12-21
Other
2021-12-23
4:40 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
253,030 $0 3,548,858
(Indirect)
View
2021-08-05
Other
2021-08-09
4:42 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
156,610 $0 5,156,011
(Direct)
View
2021-06-28
Conversion
2021-06-30
5:00 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
38,309,520 $0 8,897,053
(Direct)
View
2021-06-23
Ownership
2021-06-23
8:29 pm
N/A
N/A
Monte Rosa Therapeutics Inc. GLUE Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
0 $0 8,739,158
(Direct)
View
2021-06-01
Other
2021-06-03
4:32 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
77,247 $0 5,226,427
(Direct)
View
2021-05-12
Other
2021-05-14
4:45 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
404,844 $0 3,736,306
(Indirect)
View
2021-05-05
Other
2021-05-07
4:27 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
341,275 $0 3,397,481
(Indirect)
View
2021-03-26
Other
2021-03-30
7:05 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
404,849 $0 3,738,334
(Indirect)
View
2021-02-17
Other
2021-02-19
5:16 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
337,107 $0 5,604,496
(Direct)
View
2021-02-16
Other
2021-02-18
5:13 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
362,672 $0 3,243,572
(Indirect)
View
2021-01-29
Other
2021-02-02
6:43 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
736,081 $0 1,259,500
(Indirect)
View
2021-01-14
Other
2021-01-19
8:17 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
583,680 $0 1,155,090
(Indirect)
View
2020-12-15
Other
2020-12-17
9:05 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
325,000 $0 4,545,416
(Indirect)
View
2020-07-21
Conversion
2020-07-21
7:41 pm
N/A
N/A
Pandion Therapeutics Inc. PAND Versant Venture Capital VI L.P.
Versant Vantage I L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
21,530,967 $0 3,754,051
(Direct)
View
2020-07-16
Ownership
2020-07-16
8:38 pm
N/A
N/A
Pandion Therapeutics Inc. PAND Versant Venture Capital VI L.P.
Versant Vantage I L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
0 $0 3,754,051
(Direct)
View
2020-06-23
Conversion
2020-06-25
7:40 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
6,245,349 $0 3,419,451
(Indirect)
View
2020-06-18
Ownership
2020-06-18
9:45 pm
N/A
N/A
Repare Therapeutics Inc. RPTX Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
0 $0 6,987,679
(Indirect)
View
2020-05-18
Other
2020-05-20
9:58 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
120,148 $0 340,301
(Direct)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
4,734,769 $0 4,959,769
(Direct)
View
2020-02-27
Ownership
2020-02-27
8:07 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Vantage I L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Woiwode Thomas
10% Owner
0 $0 4,734,769
(Direct)
View
2019-11-04
Conversion
2019-11-04
5:58 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
4,667,825 $0 3,565,546
(Indirect)
View
2019-10-30
Ownership
2019-10-30
8:05 pm
N/A
N/A
Oyster Point Pharma Inc. OYST Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Ventures IV LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
10% Owner
0 $0 4,990,282
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
2,506,653 $0 2,852,656
(Indirect)
View